MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous Carcinoma

Oncogenic BRAFV600E drives expression of MGL ligands in the colorectal cancer cell line HT29 through N-acetylgalactosamine-transferase 3

(2018) Neha M. Sahasrabudhe et al.   BIOLOGICAL CHEMISTRY

The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway

(2018) Vivian M. Spaans et al.   GYNECOLOGIC ONCOLOGY

β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3–N-Glycan Complex

(2018) Yukiko Kariya et al.   MOLECULAR CANCER RESEARCH

Integrated genomic and molecular characterization of cervical cancer

(2017)   NATURE

Gynaecological cancer: Novel molecular subtypes of cervical cancer — potential clinical consequences

(2017) Chris J. L. M. Meijer et al.   Nature Reviews Clinical Oncology

Advances in diagnosis and treatment of metastatic cervical cancer

(2016) Haoran Li et al.   Journal of Gynecologic Oncology

Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix

(2016) A Marijne Heeren et al.   MODERN PATHOLOGY

Hallmarks of glycosylation in cancer

(2016) Jennifer Munkley et al.   Oncotarget

Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases

(2016) Debbie M. Ferns et al.   Journal for ImmunoTherapy of Cancer

FoxP3+ and IL-17+ cells are correlated with improved prognosis in cervical adenocarcinoma

(2015) Simone Punt et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma

(2015) S. Samuels et al.   TISSUE ANTIGENS

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients

(2015) Kristiaan Lenos et al.   Oncotarget

Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival

(2015) Debbie M Ferns et al.   OncoImmunology

Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome

(2015) Vivian M. Spaans et al.   PLoS One

Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics

(2015) Céu Costa et al.   PLoS One

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

The C-Type Lectin Macrophage Galactose-Type Lectin Impedes Migration of Immature APCs

(2014) S. J. van Vliet et al.   JOURNAL OF IMMUNOLOGY

PI3K and cancer: lessons, challenges and opportunities

(2014) David A. Fruman et al.   NATURE REVIEWS DRUG DISCOVERY

Designing a High-Throughput Somatic Mutation Profiling Panel Specifically for Gynaecological Cancers

(2014) Vivian M. Spaans et al.   PLoS One

High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer

(2014) A. M. Heeren et al.   Cancer Immunology Research

Oncogenic mutations in cervical cancer

(2013) Alexi A. Wright et al.   CANCER

Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma

(2013) P.J. de Vos van Steenwijk et al.   INTERNATIONAL JOURNAL OF CANCER

MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion

(2013) Sandra J. van Vliet et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Are the differences in treatment outcome for adenocarcinoma of the cervix different enough to change the treatment paradigm?

(2012) Peter G. Rose   GYNECOLOGIC ONCOLOGY

PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy

(2012) John B. McIntyre et al.   GYNECOLOGIC ONCOLOGY

Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10–producing suppressive CD4+T cells

(2012) Dapeng Li et al.   JOURNAL OF EXPERIMENTAL MEDICINE

HLA-E expression in cervical adenocarcinomas: association with improved long-term survival

(2012) Vivian M Spaans et al.   Journal of Translational Medicine

A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix

(2011) Walayat Shah et al.   Cellular & Molecular Immunology

Human Papillomavirus Testing in the Prevention of Cervical Cancer

(2011) Mark Schiffman et al.   JNCI-Journal of the National Cancer Institute

PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers

(2011) Filip Janku et al.   PLoS One

HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes

(2011) M. Gooden et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) C. Haie-Meder et al.   ANNALS OF ONCOLOGY

Adenocarcinoma: A unique cervical cancer

(2009) Lilian T. Gien et al.   GYNECOLOGIC ONCOLOGY

Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?

(2008) E. S. Jordanova et al.   CLINICAL CANCER RESEARCH

Classical and non-classical HLA molecules and p16INK4a expression in precursors lesions and invasive cervical cancer

(2008) Maria Alice G. Gonçalves et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology